Literature DB >> 16434572

Lithium treatment induces a marked proliferation of primarily principal cells in rat kidney inner medullary collecting duct.

Birgitte Mønster Christensen1, Young-Hee Kim, Tae-Hwan Kwon, Søren Nielsen.   

Abstract

Lithium (Li) treatment for 4 wk has previously been shown to increase the fraction of intercalated cells in parallel with a decrease in the fraction of principal cells in the kidney collecting duct (Christensen BM, Marples D, Kim YH, Wang W, Frøkiaer J, and Nielsen S. Am J Physiol Cell Physiol 286: C952-C964, 2004; Kim YH, Kwon TH, Christensen BM, Nielsen J, Wall SM, Madsen KM, Frøkiaer J, and Nielsen S. Am J Physiol Renal Physiol 285: F1244-F1257, 2003). To study how early this fractional change starts, the origin of the cells and the possible mechanism behind the changes, we did time course studies in rats subjected to different durations of Li treatment (i.e., for 4, 10, and 15 days). Increased urine output was already observed at day 4 of Li treatment with decreased AQP2 levels although not statistically significant. At days 10 and 15, both a significant polyuria and downregulation in AQP2 expression were observed. At day 10, the density of H+-ATPase-positive cells was increased in the IMCD of Li-treated rats and this was further pronounced at day 15. Some of the H+-ATPase-positive cells did not costain with Cl-/HCO3- exchanger AE1, indicating that they were not fully differentiated to type A IC. By double labeling for either H+-ATPase and proliferating-cell nuclear antigen (PCNA) or for AQP4 and PCNA, we found that proliferation mainly occurred in proximal IMCD cells at day 4 and it increased toward the middle part of the IMCD in response to prolonged Li treatment. Most cells expressing PCNA were stained with AQP4 but not with H+-ATPase. Triple-labeling for H+-ATPase, AQP4, and PCNA showed a subset of cells negative for all three proteins or only positive for PCNA. In contrast, a 4-wk recovery period after 4 wk of Li treatment reversed the enhanced proliferative rate to the control levels. In conclusion, the Li-induced increase in the density of intercalated cells is associated with a high proliferative rate of principal cells in the IM-1 and IM-2 rather than a selective proliferation of intercalated cells as expected. This is likely to contribute to the remodeling of the collecting duct after Li treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16434572     DOI: 10.1152/ajprenal.00383.2005

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  61 in total

Review 1.  Role of aquaporins in cell proliferation: What else beyond water permeability?

Authors:  Ana Galán-Cobo; Reposo Ramírez-Lorca; Miriam Echevarría
Journal:  Channels (Austin)       Date:  2016-01-11       Impact factor: 2.581

Review 2.  Targeting renal purinergic signalling for the treatment of lithium-induced nephrogenic diabetes insipidus.

Authors:  B K Kishore; N G Carlson; C M Ecelbarger; D E Kohan; C E Müller; R D Nelson; J Peti-Peterdi; Y Zhang
Journal:  Acta Physiol (Oxf)       Date:  2015-05-04       Impact factor: 6.311

3.  Role of adenylyl cyclase 6 in the development of lithium-induced nephrogenic diabetes insipidus.

Authors:  Søren Brandt Poulsen; Tina Bøgelund Kristensen; Heddwen L Brooks; Donald E Kohan; Timo Rieg; Robert A Fenton
Journal:  JCI Insight       Date:  2017-04-06

Review 4.  Molecular mechanisms in lithium-associated renal disease: a systematic review.

Authors:  Soham Rej; Shamira Pira; Victoria Marshe; André Do; Dominique Elie; Karl J Looper; Nathan Herrmann; Daniel J Müller
Journal:  Int Urol Nephrol       Date:  2016-06-29       Impact factor: 2.370

Review 5.  Advances in predictive in vitro models of drug-induced nephrotoxicity.

Authors:  Joanne Y-C Soo; Jitske Jansen; Rosalinde Masereeuw; Melissa H Little
Journal:  Nat Rev Nephrol       Date:  2018-06       Impact factor: 28.314

6.  Identification of Acer2 as a First Susceptibility Gene for Lithium-Induced Nephrogenic Diabetes Insipidus in Mice.

Authors:  Theun de Groot; Lena K Ebert; Birgitte Mønster Christensen; Karolina Andralojc; Lydie Cheval; Alain Doucet; Cungui Mao; Ruben Baumgarten; Benjamin E Low; Roger Sandhoff; Michael V Wiles; Peter M T Deen; Ron Korstanje
Journal:  J Am Soc Nephrol       Date:  2019-09-26       Impact factor: 10.121

7.  GSK3beta mediates renal response to vasopressin by modulating adenylate cyclase activity.

Authors:  Reena Rao; Satish Patel; Chuanming Hao; James Woodgett; Raymond Harris
Journal:  J Am Soc Nephrol       Date:  2010-01-07       Impact factor: 10.121

8.  Aquaporin 2-labeled cells differentiate to intercalated cells in response to potassium depletion.

Authors:  Wan-Young Kim; Sun Ah Nam; Arum Choi; Yu-Mi Kim; Sang Hee Park; Yong Kyun Kim; Jin Kim
Journal:  Histochem Cell Biol       Date:  2015-10-26       Impact factor: 4.304

Review 9.  Lithium in the Kidney: Friend and Foe?

Authors:  Mohammad Alsady; Ruben Baumgarten; Peter M T Deen; Theun de Groot
Journal:  J Am Soc Nephrol       Date:  2015-11-17       Impact factor: 10.121

10.  Acetazolamide Attenuates Lithium-Induced Nephrogenic Diabetes Insipidus.

Authors:  Theun de Groot; Anne P Sinke; Marleen L A Kortenoeven; Mohammad Alsady; Ruben Baumgarten; Olivier Devuyst; Johannes Loffing; Jack F Wetzels; Peter M T Deen
Journal:  J Am Soc Nephrol       Date:  2015-11-16       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.